Literature DB >> 27517413

Acute myeloid leukaemia-A review of sixty-seven cases.

U O'Callaghan1, D McCarthy1, J Hegarty1, F Goodwin1, J J Fennelly1, L G O'Connell1.   

Abstract

Sixty-seven consecutive patients with acute myeloid leukaemia (AML), who presented to the unit over a 5-year period, were reviewed. Remission rates, length of remission and duration of survival were studied. Twenty-seven patients (40.3%) achieved complete remission (CR). Eleven patients (16.4%) achieved a second CR. The median survival of patients who achieved a CR was 15 months. Median survival of patients who failed to go into remission was one month. Median duration of the first remission was 7 months. Three patients are still alive and in remission. These results are discussed in relation to those reported from other centres.

Entities:  

Year:  1979        PMID: 27517413     DOI: 10.1007/BF02938075

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  13 in total

1.  Treatment of Acute Leukaemia in Adults: Comparison of Steroid Therapy at High and Low Dosage in Conjunction with 6-Mercaptopurine.

Authors: 
Journal:  Br Med J       Date:  1963-01-05

2.  Maintenance immunotherapy of acute non-lymphocytic leukaemia using unirradiated blast cells and B.C.G.

Authors:  J J Fennelly; A McBride; L G O'Connell
Journal:  Biomedicine       Date:  1976-07

3.  Prolonged remission maintenance in acute myeloid leukaemia.

Authors:  A S Spiers; J M Goldman; D Catovsky; C Costello; D A Galton; C S Pitcher
Journal:  Br Med J       Date:  1977-08-27

4.  The treatment of acute granulocytic leukemia in adults.

Authors:  D S Rosenthal; W C Moloney
Journal:  N Engl J Med       Date:  1972-06-01       Impact factor: 91.245

5.  Intensive chemotherapy of acute myelogenous leukaemia.

Authors:  A Gorman; J J Fennelly; L G O'Connell
Journal:  J Ir Med Assoc       Date:  1972-10-21

6.  Management of adult acute myelogenous leukaemia.

Authors:  D Crowther; R L Powles; C J Bateman; M E Beard; C L Gauci; P F Wrigley; J S Malpas; G H Fairley; R B Scott
Journal:  Br Med J       Date:  1973-01-20

7.  epsilon-Amino-caproic acid in the management of acute promyelocytic leukaemia.

Authors:  T J Keane; A M Gorman; L G O'Connell; J J Fennelly
Journal:  Acta Haematol       Date:  1976       Impact factor: 2.195

8.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

9.  Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.

Authors:  P H Wiernik; S C Schimpff; C A Schiffer; J L Lichtenfeld; J Aisner; M J O'Connell; C Fortner
Journal:  Cancer Treat Rep       Date:  1976-01

10.  High remission-induction rate in acute myeloid leukaemia.

Authors:  R P Gale; M J Cline
Journal:  Lancet       Date:  1977-03-05       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.